« Previous
Next »
Resuscitation
Volume 81, Issue 3
, Pages 337-342
, March 2010
Can early serum levels of S100B protein predict the prognosis of patients with out-of-hospital cardiac arrest?
References
- . The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J. 1997;18:1231–1248
- Modifiable factors associated with improved cardiac arrest survival in a multicenter basic life support/defibrillation system: OPALS Study Phase I results. Ontario Prehospital Advanced Life Support. Ann Emerg Med. 1999;33:44–50
- Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: OPALS study phase II. Ontario Prehospital Advanced Life Support. JAMA. 1999;281:1175–1181
- . Clinical neurophysiologic monitoring and brain injury from cardiac arrest. Neuro Clin. 2006;24:89–106
- . Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;67:203–210
- . Electrophysiological prognostication and brain injury from cardiac arrest. Semin Neurol. 2006;26:403–412
- . SSEPs and prognosis in postanoxic coma: only short or also long latency responses?. Neurology. 2006;67:583–586
- Prediction of poor outcome within the first 3 days of postanoxic coma. Neurology. 2006;66:62–68
- . Biochemical markers (NSE, S-100, IL-8) as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation. Resuscitation. 2007;75:219–228
- . Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke. 1998;29:473–477
- . Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation. 2001;49:183–191
- Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation. 2001;103:2694–2698
- . Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation. 2005;65:49–55
- Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit Care Med. 2002;30:2669–2674
- . The current status of the emergency medical system in Korea. Am J Emerg Med. 2007;25:846–848
- . Time for change: the state of emergency medical services in South Korea. Yonsei Med J. 2006;47:587–588
- Recommended guidelines for monitoring, reporting, and conducting research on medical emergency team, outreach, and rapid response systems: an Utstein-style scientific statement. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiopulmonary, Perioperative, and Critical Care; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Resuscitation. 2007;75:412–433
- . Rapid measurement of S-100B serum protein levels by Elecsys S100 immunoassay in patients undergoing carotid artery stenting or endarterectomy. Clin Biochem. 2006;39:349–356
- Slight and short-lasting increase of serum S-100B protein in extra-cranial trauma. Brain Inj. 2006;20:867–872
- Increased levels of serum S100B protein in critically ill patients without brain injury. Shock. 2006;26:20–24
- . High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;48:1255–1258
☆ A Spanish translated version of the abstract of this article appears as Appendix in the final online version at doi:10.1016/j.resuscitation.2009.10.012.
☆☆ This study was financially supported by the Seoul National University Hospital Clinical Research Fund (2006).
◊ Sang Do Shin was invited to be present in the expert panel consensus meeting on S100 protein, which was hosted and financially supported by Roche Ltd. (Switzerland) in 2008. Shin presented the result of this study there.
PII: S0300-9572(09)00539-5
doi: 10.1016/j.resuscitation.2009.10.012
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Resuscitation
Volume 81, Issue 3
, Pages 337-342
, March 2010

